Markers of Myeloproliferative Diseases in Childhood Polycythemia Vera and Essential Thrombocythemia | Zendy

Luciana Teofili | Zendy; Fiorina Giona | Zendy; Maurizio Martini | Zendy; Tonia Cenci | Zendy; Francesco Guidi | Zendy; Lorenza Torti | Zendy; Giovanna Palumbo | Zendy; Angela Amendola | Zendy; Robin Foà | Zendy; Luigi Maria Larocca | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Markers of Myeloproliferative Diseases in Childhood Polycythemia Vera and Essential Thrombocythemia

Author(s) -

Luciana Teofili,

Fiorina Giona,

Maurizio Martini,

Tonia Cenci,

Francesco Guidi,

Lorenza Torti,

Giovanna Palumbo,

Angela Amendola,

Robin Foà,

Luigi Maria Larocca

Publication year - 2007

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2006.08.6884

Subject(s) - polycythemia vera , essential thrombocythemia , medicine , anagrelide , myeloproliferative disorders , myelofibrosis , myeloproliferative neoplasm , thrombocytosis , platelet , bone marrow

Polycythemia vera (PV) and essential thrombocythemia (ET) can present in pediatric age as sporadic or familial diseases. To define the biologic profile of childhood PV and ET, we evaluated specific markers in a cohort of pediatric patients affected by PV and ET, including cases with familial occurrence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research